Structural elucidation and antidiabetic activity of fucosylated chondroitin sulfate from sea cucumber Stichopus japonicas.


Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
15 Jun 2021
Historique:
received: 04 01 2021
revised: 15 03 2021
accepted: 17 03 2021
entrez: 11 4 2021
pubmed: 12 4 2021
medline: 25 8 2021
Statut: ppublish

Résumé

A fucosylated chondroitin sulfate was isolated from the body wall of sea cucumber Stichopus japonicus (FCSsj), whose structure was characterized by NMR spectroscopy and HILIC-FTMS. At the ratio of 1.00:0.26:0.65, three fucosyl residues were found: 2,4-disulfated-fucose (Fuc2,4S), 4-sulfated-fucose (Fuc4S) and 3,4-disulfated-fucose (Fuc3,4S), which were only linked to the O-3 of glucuronic acid residues (GlcA). Besides mono-fucosyl moieties, di-fucosyl branches, namely Fuc2,4Sα(1→3)Fuc4S, were also found to be attached to the O-3 of GlcA. The antidiabetic activity of FCSsj was evaluated using glucosamine induced insulin resistant (IR) Hep G2 cells in vitro. It was found that FCSsj significantly promoted the glucose uptake and glucose consumption of IR-Hep G2 cells in a dose-dependent manner, and could alleviate the cell damage. Furthermore, FCSsj could promote the glycogen synthesis in the glucosamine-induced IR-Hep G2 cells. These results provided a supplement for studying the antidiabetic activity of FCSsj.

Identifiants

pubmed: 33838834
pii: S0144-8617(21)00356-8
doi: 10.1016/j.carbpol.2021.117969
pii:
doi:

Substances chimiques

Hypoglycemic Agents 0
fucosylated chondroitin sulfate 0
Fucose 28RYY2IV3F
Glucuronic Acid 8A5D83Q4RW
Glycogen 9005-79-2
Chondroitin Sulfates 9007-28-7
Glucose IY9XDZ35W2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117969

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Pi-Xian Gong (PX)

Weihai Marine Organism & Medical Technology Research Institute, Harbin Institute of Technology, Weihai, 264209, PR China.

Qin-Ying Li (QY)

Weihai Marine Organism & Medical Technology Research Institute, Harbin Institute of Technology, Weihai, 264209, PR China.

Yan-Chao Wu (YC)

Weihai Marine Organism & Medical Technology Research Institute, Harbin Institute of Technology, Weihai, 264209, PR China. Electronic address: ycwu@iccas.ac.cn.

Wen-Yu Lu (WY)

Weihai Marine Organism & Medical Technology Research Institute, Harbin Institute of Technology, Weihai, 264209, PR China.

Jun Zeng (J)

Weihai Marine Organism & Medical Technology Research Institute, Harbin Institute of Technology, Weihai, 264209, PR China.

Hui-Jing Li (HJ)

Weihai Marine Organism & Medical Technology Research Institute, Harbin Institute of Technology, Weihai, 264209, PR China; Weihai Huiankang Biotechnology Co., Ltd, Weihai 264200, PR China. Electronic address: lihuijing@iccas.ac.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH